Company Filing History:
Years Active: 1998-1999
Title: Leonard Garfinkel: Innovator in Biopolymers and Cardiovascular Treatments
Introduction
Leonard Garfinkel is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications in treating cardiovascular and cerebrovascular disorders. With a total of 4 patents to his name, Garfinkel's work is paving the way for innovative medical treatments.
Latest Patents
Garfinkel's latest patents focus on methods of using human von Willebrand factor GPIb binding domain. The subject invention provides non-glycosylated, biologically active polypeptides that comprise the vWF (von Willebrand Factor) GP1b binding domain. These polypeptides may be used to inhibit platelet adhesion and aggregation in the treatment of subjects with conditions such as cerebrovascular and cardiovascular disorders. This invention also includes expression plasmids encoding these polypeptides, as well as methods of producing them by transforming a bacterial cell and recovering such polypeptides. Furthermore, the invention provides methods of treating and preventing cerebrovascular, cardiovascular, and other disorders using these polypeptides to inhibit platelet aggregation.
Career Highlights
Leonard Garfinkel is associated with Bio-Technology General Corporation, where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the understanding and treatment of blood-related disorders.
Collaborations
Garfinkel collaborates with various professionals in the field, including his coworker Tamar Richter, to enhance the impact of his inventions and research.
Conclusion
Leonard Garfinkel's contributions to biotechnology and his innovative patents are making a significant impact in the medical field. His work continues to inspire advancements in treatments for serious health conditions.